The Royal Canadian Mounted Police (RCMP) Forensic Laboratory Services (FLS) needed a method to confirm positive lysergic acid diethylamide (LSD) immunoassay screening results. As a result, an ultra performance liquid chromatography tandem mass spectrometry (UPLC¢â/MS/MS) method was validated for the confirmation and quantitation of LSD, iso-LSD, N-demethyl-LSD (nor-LSD), and 2-oxo-3-hydroxy-LSD (O-H-LSD). The method was validated in urine and whole blood, where linearity, accuracy, precision, sensitivity, stability, selectivity, recovery, matrix effects, and reproducibility were evaluated. <p>The method involved a liquid-liquid extraction (LLE) of the analytes and the deuterated internal standard from 1 mL of urine or whole blood with dichloromethane:isopropyl alcohol after being basified. The average recovery for all analytes was ¡Ã 62%, and the matrix effect was found to be insignificant. MS/MS analysis was conducted with a triple quadrupole mass spectrometer by positive electrospray ionization (ESI+) in multiple reaction monitoring (MRM) mode. The lowest limit of quantitation (LLOQ) was 20 pg/mL for LSD and iso-LSD, and 50 pg/mL for nor-LSD and O-H-LSD. The method was linear, accurate, precise, selective, and reproducible from 20 to 2000 pg/mL for LSD and iso-LSD, and from 50 to 2000 pg/mL for nor-LSD and O-H-LSD with an r2 ¡Ã 0.99. <p>The refrigerated and frozen long term stability was investigated for 90 days. LSD was stable at all temperatures for 90 days. Iso-LSD in blood was also stable at all temperatures for 90 days, but iso-LSD in urine showed an initial decrease followed by a gradual increase back to day 0 concentrations. Nor-LSD was stable at all temperatures up to day 14, with >43% decrease by day 30, with no additional decrease for the next 60 days. O-H-LSD in urine was stable at all temperatures for 90 days, but by day 90 O-H-LSD in whole blood stored refrigerated decreased in concentration by >37%. Additionally, a case sample that was stored at -50¡ÆC for ten years was found to still contain measurable amounts of each compound. <p>The method was applied to blind samples and a case that screened positive with immunoassay. Retention time, relative retention time, and ion ratios were used as identification parameters and found to correctly identify the analytes 100% of the time with no false positives. The case sample showed that the concentration of O-H-LSD was 4 times greater than LSD in urine. Furthermore, both the detection of O-H-LSD in a blood case sample, and LSD in a vitreous humor case sample were the first to be documented.

The Royal Canadian Mounted Police (RCMP) Forensic Laboratory Services (FLS) needed a method to confirm positive lysergic acid diethylamide (LSD) immunoassay screening results. As a result, an ultra performance liquid chromatography tandem mass spectrometry (UPLC¢â/MS/MS) method was validated for the confirmation and quantitation of LSD, iso-LSD, N-demethyl-LSD (nor-LSD), and 2-oxo-3-hydroxy-LSD (O-H-LSD). The method was validated in urine and whole blood, where linearity, accuracy, precision, sensitivity, stability, selectivity, recovery, matrix effects, and reproducibility were evaluated. <p>The method involved a liquid-liquid extraction (LLE) of the analytes and the deuterated internal standard from 1 mL of urine or whole blood with dichloromethane:isopropyl alcohol after being basified. The average recovery for all analytes was ¡Ã 62%, and the matrix effect was found to be insignificant. MS/MS analysis was conducted with a triple quadrupole mass spectrometer by positive electrospray ionization (ESI+) in multiple reaction monitoring (MRM) mode. The lowest limit of quantitation (LLOQ) was 20 pg/mL for LSD and iso-LSD, and 50 pg/mL for nor-LSD and O-H-LSD. The method was linear, accurate, precise, selective, and reproducible from 20 to 2000 pg/mL for LSD and iso-LSD, and from 50 to 2000 pg/mL for nor-LSD and O-H-LSD with an r2 ¡Ã 0.99. <p>The refrigerated and frozen long term stability was investigated for 90 days. LSD was stable at all temperatures for 90 days. Iso-LSD in blood was also stable at all temperatures for 90 days, but iso-LSD in urine showed an initial decrease followed by a gradual increase back to day 0 concentrations. Nor-LSD was stable at all temperatures up to day 14, with >43% decrease by day 30, with no additional decrease for the next 60 days. O-H-LSD in urine was stable at all temperatures for 90 days, but by day 90 O-H-LSD in whole blood stored refrigerated decreased in concentration by >37%. Additionally, a case sample that was stored at -50¡ÆC for ten years was found to still contain measurable amounts of each compound. <p>The method was applied to blind samples and a case that screened positive with immunoassay. Retention time, relative retention time, and ion ratios were used as identification parameters and found to correctly identify the analytes 100% of the time with no false positives. The case sample showed that the concentration of O-H-LSD was 4 times greater than LSD in urine. Furthermore, both the detection of O-H-LSD in a blood case sample, and LSD in a vitreous humor case sample were the first to be documented.

In this study, I use SCOT (Social Construction of Technology) theories to trace the history of lysergic acid diethylamide-25, which is commonly known as LSD. I show how the technological system of LSD corresponds to phases designated by SCOT theorist Thomas Hughes, specifically invention, development, innovation, growth, competition, and consolidation. I explain the importance of Timothy Leary and the CIA in the social construction of the LSD system, and their influences on the transformation of LSD from a chemical technology to a highly controversial drug. Finally, I discuss the fate of LSD research today, its usage among members of the public, especially youngsters, and the usefulness of SCOT theories for this study. / Master of Science

Includes supplementary material. / CAPSTONE PROJECT REPORT / System Engineering and Analysis Cohort 18A and Temasek Defense Systems Institute / Approved for public release, distribution unlimited / The aging Whidbey Island and Harpers Ferry class ships, LSD-41 and 49 respectively, comprise just over one third of the amphibious navy. However, a solution to the capability gap created by the loss of these ships is needed to maintain the effectiveness of the amphibious fleet across a broad spectrum of mission areas. This research effort considers future ship designs and fleet architectures to meet the capability gaps left by the decommissioning of the LSD-41 and 49 class ships. With respect to lift capacity, performance capability, cost and a risk assessment, the analysis showed the LPD-17 or a LSD(X) approximately 30% larger than the existing classes to be acceptable replacement classes. This analysis also supports further research to determine the most robust fleet architecture apart from the current eleven LHA or LHD, eleven LPD and eleven LSD paradigm.

The controversy surrounding the use of LSD as an adjunct to psychotherapy for alcoholics in Saskatchewan has not been explored by social or medical historians. From 1950 to 1967, Saskatchewan psychiatrists developed new treatments for chronic alcoholism by using LSD on themselves, on volunteers and finally on patients. Despite early success and praise, the use of LSD in psychotherapy was later condemned by the media, the general public, the medical profession and eventually the federal government and was discontinued after being banned in 1967. The reasons for the ban were far-reaching and diverse. LSD was exploited by the counter-culture for "kicks" and was later abandoned by pharmaceutical companies because of the negative reputation lay-professionals and the media had bestowed upon its therapeutic use. As it turned out, legitimate LSD research became too clouded in controversy to survive the 1960s as researchers failed to convince the masses that the drug did not pose a threat to the well-being of society. In many respects, the LSD controversy can be seen as more of a moral panic than a scientific debate. Nevertheless, the LSD controversy provides a unique and much needed look into the history of medicine from a social perspective, illustrating that social values often have more impact on medical research than empirical validity. As recent evidence suggests, the psychotherapeutic potential of LSD -- as developed by Saskatchewan psychiatrists -- has not been forgotten. Indeed, a renewal of interest in LSD research has surfaced in several U.S. states as American psychiatrists are discovering, once again, that LSD can be a valuable psychiatric research tool.

The controversy surrounding the use of LSD as an adjunct to psychotherapy for alcoholics in Saskatchewan has not been explored by social or medical historians. From 1950 to 1967, Saskatchewan psychiatrists developed new treatments for chronic alcoholism by using LSD on themselves, on volunteers and finally on patients. Despite early success and praise, the use of LSD in psychotherapy was later condemned by the media, the general public, the medical profession and eventually the federal government and was discontinued after being banned in 1967. The reasons for the ban were far-reaching and diverse. LSD was exploited by the counter-culture for "kicks" and was later abandoned by pharmaceutical companies because of the negative reputation lay-professionals and the media had bestowed upon its therapeutic use. As it turned out, legitimate LSD research became too clouded in controversy to survive the 1960s as researchers failed to convince the masses that the drug did not pose a threat to the well-being of society. In many respects, the LSD controversy can be seen as more of a moral panic than a scientific debate. Nevertheless, the LSD controversy provides a unique and much needed look into the history of medicine from a social perspective, illustrating that social values often have more impact on medical research than empirical validity. As recent evidence suggests, the psychotherapeutic potential of LSD -- as developed by Saskatchewan psychiatrists -- has not been forgotten. Indeed, a renewal of interest in LSD research has surfaced in several U.S. states as American psychiatrists are discovering, once again, that LSD can be a valuable psychiatric research tool. / Arts, Faculty of / History, Department of / Graduate

Thesis (Ph. D.)--University of Texas at Austin, 2002. / Vita. Includes bibliographical references. Available also from UMI Company.

Not available / text

Magíster en Psicología Clínica de Adultos / En la presente investigación cualitativa se describen las psicoterapias asistidas con LSD, psilocibina y MDMA, a partir de entrevistas realizadas a algunos terapeutas que las llevan a cabo con sus pacientes. Para ello se ha indagado en ciertos aspectos que articulan la clínica, tales como sus fases, sus objetivos, la cura, el terapeuta, el vínculo entre paciente y terapeuta, el lugar de trabajo y las técnicas que se utilizan; entre las que se encuentran los usos de sustancias psicoactivas. Utilizando una metodología de análisis de contenido, se han observado diversos tipos de psicoterapias asistidas con fármacos, así como algunas de las dimensiones que las atraviesan: política, real y corporal. También se ha realizado una clasificación de los efectos catalizadores que comparten la LSD, la psilocibina y la MDMA, y que pueden ser de interés para ser utilizados en psicoterapia. Además, destaca el cuerpo como una dimensión en la que convergen: la emergencia de las problemáticas del sujeto, con los efectos potenciadores de las drogas y las formas de intervención del terapeuta. Así mismo resaltan ciertos elementos del lugar de trabajo como vehiculizadores de las experiencias que acontecen con dichas sustancias, como son el elemento sonoro y el espacio exterior, los que bajo un cierto ordenamiento encausan al sujeto hacia lo terapéutico. También se han realizado algunas reflexiones y vínculos entre los postulados de Sigmund Freud y Stanislav Grof respecto de los estados de conciencia y su emergencia en el campo psicoterapéutico. Además, se han encontrado diversas convergencias y divergencias entre el marco analítico y el de terapias asistidas que se realiza hoy en día. Asimismo han aparecido cuatro aspectos que son propios de la clínica y que permiten diferenciar las experiencias terapéuticas de las recreacionales que se pueden llegar a tener con LSD, psilocibina y MDMA. Estas consideraciones permiten concluir que es en la relación que establece un sujeto con su estado modificado de conciencia donde residen las posibilidades terapéuticas, y no tanto en los efectos directos de la sustancia que se ingiere. Del mismo modo, lo encontrado en este estudio muestra de qué maneras las terapias asistidas han evolucionado tomando los planteamientos freudianos hasta emerger de la forma que las caracteriza en la actualidad

Thesis (Ph.D.)--Ohio University, November, 2008. / Abstract only has been uploaded to OhioLINK. Includes bibliographical references (leaves [256]-287)